Sanna Bastiano's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 3, 2022
- Accession no.
- 0001209191-22-006792
- Filed
- Feb 3, 2022
- Trade date
- Feb 1-2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $261.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sanna BastianoCIK 0001829069 | Officer (EVP, Cell & Genetic Therapies) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2022 | Common Stock | AGrant or awardAcquired | +11,628 | $0.00 | $0 | 44,204 | Direct | |
| Feb 1, 2022 | Common Stock | AGrant or awardAcquired | +12,314 | $0.00 | $0 | 56,518 | Direct | |
| Feb 1, 2022 | Common Stock | FTax withholdingDisposed | −526 | $243.64 | −$128,154.64 | 55,992 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −670 | $250.04F4,F5 | −$167,526.8 | 55,322 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −141 | $251.47F5,F6 | −$35,457.27 | 55,181 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −149 | $253.07F5,F7 | −$37,707.43 | 55,032 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −64 | $253.95F5,F8 | −$16,252.8 | 54,968 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −16 | $254.54F5,F9 | −$4,072.64 | 54,952 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Open market sales reported on this line occurred at a weighted average price of $250.04 (range $250.00 to $250.97).
Referenced by the price of 1 transaction in Table I.
- F5
Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $251.47 (range $251.09 to $251.85).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $253.07 (range $252.44 to $253.42).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $253.95 (range $253.47 to $254.42).
Referenced by the price of 1 transaction in Table I.
- F9
Open market sales reported on this line occurred at a weighted average price of $254.54 (range $254.47 to $254.80).
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit 24 - Power of Attorney